PharmaResearch Co., Ltd. (KOSDAQ: 214450)
184,600
-3,700 (-1.96%)
Sep 11, 2024, 9:00 AM KST
PharmaResearch Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Cash & Equivalents | 95,075 | 67,245 | 72,931 | 41,674 | 26,715 | 19,738 | Upgrade
|
Short-Term Investments | 77,503 | 56,549 | 67,989 | 2,000 | 8,981 | 3,000 | Upgrade
|
Trading Asset Securities | 33,496 | 36,505 | 43,423 | 113,123 | 43,571 | 46,292 | Upgrade
|
Cash & Short-Term Investments | 206,074 | 160,298 | 184,343 | 156,798 | 79,267 | 69,029 | Upgrade
|
Cash Growth | 7.61% | -13.04% | 17.57% | 97.81% | 14.83% | -8.44% | Upgrade
|
Accounts Receivable | 32,339 | 31,400 | 32,304 | 27,741 | 22,827 | 20,197 | Upgrade
|
Other Receivables | 2,993 | 3,301 | 2,757 | 975.32 | 873.4 | 375.03 | Upgrade
|
Receivables | 37,123 | 35,998 | 36,234 | 30,490 | 26,343 | 20,572 | Upgrade
|
Inventory | 53,282 | 50,232 | 24,453 | 17,342 | 20,781 | 13,928 | Upgrade
|
Prepaid Expenses | 956.86 | 1,191 | 667.94 | 701.54 | 373.73 | 97.21 | Upgrade
|
Other Current Assets | 14,688 | 8,746 | 1,647 | 1,460 | 639.42 | 846.03 | Upgrade
|
Total Current Assets | 312,123 | 256,465 | 247,345 | 206,792 | 127,404 | 104,473 | Upgrade
|
Property, Plant & Equipment | 138,391 | 123,061 | 117,960 | 109,481 | 94,046 | 73,886 | Upgrade
|
Long-Term Investments | 90,167 | 96,951 | 40,718 | 44,911 | 42,511 | 39,356 | Upgrade
|
Goodwill | 11,652 | 11,652 | 13,810 | 16,764 | 12,492 | 13,738 | Upgrade
|
Other Intangible Assets | 19,113 | 18,709 | 22,720 | 24,825 | 26,233 | 29,806 | Upgrade
|
Long-Term Deferred Tax Assets | 5,687 | 4,476 | 8,667 | 3,166 | 3,162 | 2,292 | Upgrade
|
Long-Term Deferred Charges | 1,377 | 1,614 | 1,297 | 1,200 | 578.13 | - | Upgrade
|
Other Long-Term Assets | 19,802 | 18,415 | 21,105 | 15,715 | 13,407 | 2,752 | Upgrade
|
Total Assets | 601,474 | 535,281 | 478,055 | 427,647 | 319,831 | 269,925 | Upgrade
|
Accounts Payable | 10,208 | 2,831 | 3,527 | 2,939 | 1,876 | 5,359 | Upgrade
|
Accrued Expenses | 1,410 | 974.34 | 860.08 | 702.95 | 533.87 | 492.04 | Upgrade
|
Short-Term Debt | 31,784 | 32,345 | 18,867 | 18,873 | 17,854 | 1,236 | Upgrade
|
Current Portion of Long-Term Debt | - | 33.3 | 87.4 | 726.52 | 610 | 1,913 | Upgrade
|
Current Portion of Leases | 1,343 | 628.25 | 1,620 | 1,161 | 1,117 | 358.34 | Upgrade
|
Current Income Taxes Payable | 15,449 | 11,357 | 10,136 | 6,851 | 6,222 | 3,584 | Upgrade
|
Current Unearned Revenue | 23.83 | 27.69 | 11.36 | - | - | - | Upgrade
|
Other Current Liabilities | 24,603 | 17,703 | 19,144 | 16,751 | 7,637 | 5,648 | Upgrade
|
Total Current Liabilities | 84,821 | 65,899 | 54,253 | 48,005 | 35,849 | 18,590 | Upgrade
|
Long-Term Debt | 208.24 | 970.72 | 45,359 | 43,385 | 10,505 | 16,496 | Upgrade
|
Long-Term Leases | 1,717 | 329.91 | 835.48 | 1,466 | 2,324 | 939.83 | Upgrade
|
Long-Term Deferred Tax Liabilities | 2,602 | 2,794 | 3,741 | 4,514 | 4,746 | 5,404 | Upgrade
|
Other Long-Term Liabilities | 1,604 | 1,911 | 1,648 | 1,175 | 1,133 | 72.86 | Upgrade
|
Total Liabilities | 92,366 | 73,087 | 106,399 | 99,288 | 55,420 | 41,502 | Upgrade
|
Common Stock | 5,207 | 5,160 | 5,056 | 5,056 | 4,895 | 4,777 | Upgrade
|
Additional Paid-In Capital | 183,392 | 175,428 | 157,582 | 152,413 | 133,405 | 126,652 | Upgrade
|
Retained Earnings | 299,725 | 260,787 | 190,862 | 154,018 | 112,615 | 82,783 | Upgrade
|
Treasury Stock | -4,638 | -4,638 | -5,260 | -5,260 | -5,260 | -5,260 | Upgrade
|
Comprensive Income & Other | -2,933 | -3,633 | -4,737 | -785.15 | -232.35 | 121.9 | Upgrade
|
Total Common Equity | 480,751 | 433,104 | 343,503 | 305,442 | 245,423 | 209,075 | Upgrade
|
Minority Interest | 27,549 | 29,091 | 28,153 | 22,917 | 18,989 | 19,349 | Upgrade
|
Shareholders' Equity | 509,107 | 462,195 | 371,656 | 328,359 | 264,411 | 228,424 | Upgrade
|
Total Liabilities & Equity | 601,474 | 535,281 | 478,055 | 427,647 | 319,831 | 269,925 | Upgrade
|
Total Debt | 35,052 | 34,307 | 66,768 | 65,611 | 32,410 | 20,943 | Upgrade
|
Net Cash (Debt) | 171,022 | 125,991 | 117,575 | 91,187 | 46,857 | 48,087 | Upgrade
|
Net Cash Growth | 21.85% | 7.16% | 28.94% | 94.61% | -2.56% | -12.67% | Upgrade
|
Net Cash Per Share | 15161.59 | 11931.85 | 11785.88 | 9070.92 | 4928.76 | 5095.13 | Upgrade
|
Filing Date Shares Outstanding | 10.29 | 10.2 | 9.98 | 9.98 | 9.65 | 9.42 | Upgrade
|
Total Common Shares Outstanding | 10.29 | 10.2 | 9.98 | 9.98 | 9.65 | 9.42 | Upgrade
|
Working Capital | 227,302 | 190,566 | 193,092 | 158,787 | 91,555 | 85,883 | Upgrade
|
Book Value Per Share | 46706.30 | 42459.18 | 34433.24 | 30617.96 | 25424.37 | 22197.68 | Upgrade
|
Tangible Book Value | 449,986 | 402,743 | 306,974 | 263,854 | 206,698 | 165,531 | Upgrade
|
Tangible Book Value Per Share | 43717.33 | 39482.74 | 30771.48 | 26449.11 | 21412.71 | 17574.63 | Upgrade
|
Land | 18,617 | 18,617 | 18,617 | 14,064 | 14,064 | 7,081 | Upgrade
|
Buildings | 81,758 | 81,472 | 80,151 | 52,235 | 52,135 | 45,537 | Upgrade
|
Machinery | 45,618 | 41,375 | 30,766 | 27,162 | 22,544 | 21,806 | Upgrade
|
Construction In Progress | 26,849 | 12,459 | 12,200 | 32,985 | 16,386 | 9,515 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.